摘要
肿瘤标记物是细胞癌变过程中产生的在正常细胞中缺乏或含量极微的特异性和相对特异性的物质,也可能是宿主细胞针对癌细胞产生的正常细胞成分,但在量和质上与正常状态或良性疾病时明显不同。通过化学、免疫、分子生物学等技术对血液、体液、提取液等进行定性或定量检测,对肿瘤的诊断、治疗效果和判断预后均有重要的的临床意义。CA72-4作为一种较新的肿瘤标记物,在多种肿瘤(如胃癌、卵巢癌、结直肠癌等)的诊断、鉴别诊断、病情监测及预后评估中的作用日益受到重视。CA72-4联合其他肿瘤标记物的检测,有利于肿瘤的早发现、早诊断和早治疗。
Tumor markers are the specific and relatively specific substances which are lack or few in normal cells produced in the canceration process.They also may be the component of normal cells produced by host cells versus cancer cells,with different quantity and quality from that in normal condition or benign diseases.The detection of blood,body fluid,extract through technology of chemistry,immunity,and molecular biology plays an important role on diagnosis,treatment,prognosis of tumors.CA72-4 is a new tumor marker.People begin to attach importance to its role on diagnosis,differential diagnosis,illness monitoring and prognostic assessment of various cancers（such as gastric cancer,ovarian cancer and colorectal cancer,et al） .Combined with other tumor markers,it will be beneficial to earlier detection,earlier diagnosis and earlier treatment.
出处
《国际妇产科学杂志》
CAS
2011年第6期534-536,545,共4页
Journal of International Obstetrics and Gynecology
